Mao Ye

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (79)

• Engineered Anchoring Aptamers Induce Relocalization and Functional Inactivation of Transcription Factors
  Science Advances 2026 DOI: 10.1126/sciadv.adw6496
  +Save
• Development of an Aptamer-Based Molecular Tool for Specifically Targeting Microglia via the CD64 Protein
  Analytical Chemistry 2023 DOI: 10.1021/acs.analchem.2c04084
  +Save
• Bispecific Aptamer-Based Recognition-then-Conjugation Strategy for PD1/PDL1 Axis Blockade and Enhanced Immunotherapy
  ACS Nano 2022 DOI: 10.1021/acsnano.2c09093
  +Save
• Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1
  Oncogene 2022 DOI: 10.1038/s41388-021-02167-9
  +Save
• CD71-Specific Aptamer Conjugated with Monomethyl Auristatin E for the Treatment of Uveal Melanoma
  ACS Applied Materials & Interfaces 2022 DOI: 10.1021/acsami.1c13980
  +Save
• Lateral Flow Strip Assay for Detection of Mycoplasma hyorhinis Based on a Pair of Sandwich-Type Aptamers
  Journal of biomedical nanotechnology 2022 DOI: 10.1166/jbn.2022.3230
  +Save
• Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma
  Cancer Letters 2021 DOI: 10.1016/j.canlet.2021.08.009
  +Save
• Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for in Vivo Imaging
  ACS Applied Materials and Interfaces 2021 DOI: 10.1021/acsami.1c12391
  +Save
• Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor-selective degradation of nucleolin
  bioRxiv 2021 DOI: 10.1101/2021.08.05.455211
  +Save
• Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
  Frontiers in Pharmacology 2021 DOI: 10.3389/fphar.2020.583914
  +Save
• The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells
  Journal of Cellular and Molecular Medicine 2021 DOI: 10.1111/jcmm.16243
  +Save
• Venous thromboembolic events in patients with COVID-19: A systematic review and meta-analysis
  Age and Ageing 2021 DOI: 10.1093/ageing/afaa259
  +Save
• Antitumor Drug Combretastatin-A4 Phosphate Aggravates the Symptoms of Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
  Frontiers in Pharmacology 2020 DOI: 10.3389/fphar.2020.00339
  +Save
• Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway
  British Journal of Haematology 2020 DOI: 10.1111/bjh.16477
  +Save
• Multi-organ dysfunction in patients with COVID-19: A systematic review and meta-analysis
  Aging and Disease 2020 DOI: 10.14336/AD.2020.0520
  +Save
• NONO and tumorigenesis: More than splicing
  Journal of Cellular and Molecular Medicine 2020 DOI: 10.1111/jcmm.15141
  +Save
• The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma
  British Journal of Haematology 2020 DOI: 10.1111/bjh.16614
  +Save
• A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein
  Molecular Therapy - Nucleic Acids 2019 DOI: 10.1016/j.omtn.2019.10.005
  +Save
• C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer
  Theranostics 2019 DOI: 10.7150/thno.34887
  +Save
• Correction : Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC (Oncotarget (2016) 7 (509-523) DOI: 10.18632/oncotarget.6312)
  Oncotarget 2019
  +Save